Get started
Author

Panos Arvanitis

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
2022 · Ziad Bakouny, Chris Labaki, et al. · JAMA Oncology · 54
PDF
Pathogenesis, Diagnosis, and Management of Cytokine Release Syndrome in Patients with Cancer: Focus on Infectious Disease Considerations
2025 · Panos Arvanitis, Andreas Tziotis, et al. · Current Oncology · 25
mRNA Vaccination Decreases COVID-19-Associated Morbidity and Mortality Among Organ Transplant Recipients: A Contemporary Cohort Study
2022 · Alexis Hope Lerner, Panos Arvanitis, et al. · Open Forum Infectious Diseases · 15
PDF
Progressive Multifocal Leukoencephalopathy Unmasked by Teclistamab in a Refractory Multiple Myeloma Patient
2024 · Panos Arvanitis, Dimitrios Farmakiotis, et al. · Current Oncology · 12
Single‐center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression
2022 · Krista Mecadon, Panos Arvanitis, et al. · Clinical Transplantation · 12
Cytomegalovirus infection and cardiovascular outcomes in abdominal organ transplant recipients: A systematic review and meta-analysis
2024 · Panos Arvanitis, Michel R. Davis, et al. · Transplantation Reviews · 10
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19
2023 · Shuchi Gulati, Chih-Yuan Hsu, et al. · JAMA Oncology · 10
PDF
Oral antivirals for COVID-19 among patients with cancer
2024 · Dorra Guermazi, Panos Arvanitis, et al. · Supportive Care in Cancer · 6
PDF
Outpatient anti-spike monoclonal antibody administration is associated with decreased morbidity and mortality among patients with cancer and COVID-19
2023 · Panos Arvanitis, Alexis Hope Lerner, et al. · Clinical and Experimental Medicine · 5
PDF
Perceptions of COVID-19 Vaccination Among Organ Transplant Recipients
2024 · River Lerner, Panos Arvanitis, et al. · Transplantation Proceedings · 4
The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study
2024 · Cecilia A. Castellano, Tianyi Sun, et al. · Cancer · 3
PDF
Molnupiravir efficacy among immunocompromised patients with COVID-19: no proof of concept
2023 · Dorra Guermazi, Panos Arvanitis, et al. · Infection · 3
PDF
Red Blood Cell Exchange Transfusion for Severe Babesiosis
2026 · STOP-BABESIOSIS Investigators, David E. Leaf, et al. · JAMA Internal Medicine · 2
Medical malpractice in organ transplantation: public allegations and key legal outcomes
2024 · Panos Arvanitis, Michel R. Davis, et al. · Frontiers in Health Services · 2
PDF
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma
2023 · Douglas B. Johnson, Michael B. Atkins, et al. · BMC Cancer · 2
PDF
Advances in the Diagnosis of Invasive Pulmonary Mold Infections: Focus on Diagnostic Performance and Cost-Effectiveness of Diagnostic Tests
2026 · Spyridon Papadimatos, Andreas Tziotis, et al. · Diagnostics
PDF
COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium
2026 · Alaina J. Brown, Chih-Yuan Hsu, et al. · JCO oncology advances.
508. Nirmatrelvir/ritonavir use among patients with cancer and COVID-19 is associated with improved clinical outcomes: Single-institution case-control study
2023 · Panos Arvanitis, Kendra Vieira, et al. · Open Forum Infectious Diseases
PDF
631. Using a commercially available assay that measures cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity to predict protection against CMV: Results from a prospective, blinded clinical trial
2023 · Nouf K Almaghlouth, Panos Arvanitis, et al. · Open Forum Infectious Diseases
PDF
Works count: 19
Citation count: 164
H-index: 7
I10-index: 7
Year
Topic
Type